HTGF is a venture capital investor for innovative technologies and business models. We successfully support the best founders whose ideas can revolutionise entire industries and improve people’s lives – from seed to exit.
As a seed investor, we have already financed more than 600 start-ups in the industrial tech, digital tech, life sciences and chemicals sectors. We have overseen more than 130 exits, including IPOs. When founding your company together with us, you benefit from an experienced partner at your side. Further information for founders
We are a public–private partnership that works closely and successfully with companies from a wide range of industries. Our more than 30 fund investors include medium-sized companies, family businesses and corporations. We provide them with access to innovative start-ups and technologies insights into deal flows and connections to our global network. Further information for fund investors
More than
130
Exits & IPOs
More than
600
Investments
895 M €
Mio. under Management
35
Fund investors
Our portfolio
Our investment companies are the heart of HTGF. We are proud of each and every one of them. Our investment managers have a direct line to the founders and are on hand with support and the entire HTGF network.
HTGF shares its experience with us in matters of reporting, for example. That helps enormously when it comes to optimizing processes on the one hand and remaining transparent on the other. However, the investor never intervenes more deeply than necessary, so that our start-up momentum is maintained.
Dipl. Ing. Miriam HaerstCo-founder and managing partner
HTGF has developed a very rational and scientific approach to addressing problems in start-ups. I like that. The experience and the breadth of the portfolio make that possible.
Pierre BaquéCo-Founder / CEO – Neutral Concept Ltd.
Participating in HTGF’s network as a start-up cannot be overstated. We met our first customer at an HTGF event, even though we weren’t even in the portfolio at the time.
Philipp BürlingFounder Numaferm GmbH
HTGF has supported us unconditionally for many years. On the journey of a startup, many things develop differently than expected. We entrepreneurs therefore need a partner who supports us with advice and peace of mind to get up anew each time and make things better.
Philipp Roesch-SchlandererFounder and managing director eGym
HTGF was the first investor who understood our idea and vision and invested pre-product.
Julia Bösch Founder and managing director OUTFITTERY
We really enjoy being at the HTPC every year. This is where we meet corporate champions from large industrial companies who pass us on to the relevant contacts. That’s worth its weight in gold for our business development.
Dr. Tim PohlmannFounder and managing director IPlytics GmbH
At Family Day, we found a strong investor for our follow-on financing.
Felix BrandFounder and managing director CardioSecur
Insights
Press
23. June 2021
Spacing rules in the brain: Novel compounds that act as molecular spacers in the brain prevent neurodegeneration
High-Tech Gründerfonds (HTGF) provides seed funding for the neuro start-up FundaMental Pharma GmbH (FMP), a spin-off of the Interdisciplinary Center for Neuroscience (IZN) at Heidelberg University. FMP scientists have discovered a “death complex” in neurons whose activation leads to neurodegeneration. With the identification of a novel class of drugs, the FMP has also laid the foundation for successfully combating life-threatening neurological diseases. The financing makes it now possible t
Press
23. June 2021
Successful Exit for Creathor Ventures, High-Tech Gründerfonds, Bayern Kapital and KfW – PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech
SIRION Biotech, Martinsried near Munich, will continue to grow its leading position in viral vector technologies for cell and gene therapy as part of PerkinElmerThe addition of SIRION’s offerings will complement PerkinElmer’s Horizon Discovery portfolioIn 2007 High-Tech Gründerfonds, Creathor Ventures together with KfW and Bayern Kapital were the first seed investors of SIRION Biotech GmbHThe transaction is subject to regulatory approvals
Bonn, 23.06.2021 – High-Tech Gründerfonds,
Blog
27. May 2021
Full speed ahead in the same boat – A talk about Simplaex and Numaferm’s cooperation
Let’s be honest, for a seed investor like HTGF, it’s great when portfolio companies connect and then go on to work together. And that’s exactly what happened with digital agency Ogno, a product of Simplaex, and life sciences company Numaferm. We sat down for a chat with Simplaex co-founder and head Jeff van Ede, his marketing colleague Jesse Bondar, and Christian Schwarz, CEO and co-founder of Numaferm. It resulted in an honest talk about trust, collaboration and how an investor c
Finding a promising Start-up is our expertise, then leading it to a successful exit is our job. We are very proud of every sale, in most cases to grow further with even more energy.
We work as a team. Our investment managers contribute a great deal of experience and expertise. They are not only financing experts, but many of them have also founded their own companies or bring years of industry experience or specialized scientific know-how with them.
Our start-ups become part of the #HTGFFamily, one of the strongest networks in the high-tech venture sector, where we use our expertise to actively support growth, customer acquisition, hiring, co-investment and follow-up financing.
Become Part of the HTGF Family
Are you the founder of a high-tech start-up? Does your company match our industry focus and meet our investment criteria? Then we look forward to getting to know you and your company! Send us your pitch deck – we’ll be in touch.
Sector focus?
We invest in start-ups in the fields of industrial technology, digital tech, life sciences and chemistry.
Investment criteria?
Your start-up is less than three years old and its headquarters are in Germany. Start-ups from abroad need a clear connection to Germany.
Financing?
We invest flexibly according to the needs of the start-up.
Investment volume?
In the seed round up to 1 million euros. In total we can invest up to 3 million euros in a start-up.
Added Value?
We are sparring partners in all questions regarding the development of start-ups and will open doors for you.
Sector focus? 
Investment criteria? 
Financing? 
Investment volume? 
Added Value?